Nationwide recall of Pillsbury flour due to salmonella fears

More than 12,000 cases of the unbleached flour have been sold nationwide at retailers including Meijer, Publix and Winn-Dixie

• Mar 13, 2019

After multiple recalls, FDA OK's new generic for valsartan

FDA said new approval will help alleviate shortages of blood pressure drugs after repeated recalls over cancer-causing chemicals

• Mar 13, 2019

Texas company recalls contaminated water, then shuts down

Federal watchdog finds potentially dangerous bacteria in one product and a skin-burning chemical in another

• Mar 8, 2019

Some Claire's makeup contains asbestos and shouldn't be used, FDA says

The FDA said its tests confirm earlier reports that some Claire's makeup contained the mineral, which is linked to cancer

• Mar 6, 2019

Ketamine approved to treat depression

The FDA on Tuesday approved a nasal spray form of ketamine, a rapid acting anesthetic that has been used illegally as a party drug known as "Special K," to treat depression. The nasal spray can only be accessed in a doctor's office.

• Mar 5, 2019
• 0:43

FDA approves form of ketamine for depression treatment

In the 1990s, the medication was adopted as a party drug by the underground rave culture due to its ability to produce psychedelic, out-of-body experiences

• Mar 5, 2019

FDA commissioner who sounded alarm on teen vaping submits resignation

Gottlieb has submitted his paperwork for resignation, "but he will be on for at least another month," an administration official said

• Mar 5, 2019

Ketamine spray could help treat depression

The FDA is expected to approve a new ketamine nasal spray to help treat depression. CBS News chief medical correspondent Dr. Jonathan LaPook joins CBSN to talk about the benefits and risks.

• Mar 5, 2019
• 7:39

FDA to require research of long-term opioid use

The mandate follows a 60 Minutes report on how a label change fueled the opioid crisis

• Mar 5, 2019

Ketamine spray could be approved for depression

The FDA may be on the verge of approving the first new treatment for depression in decades. It involves a form of ketamine used as a nasal spray. Dr. Jon LaPook explains.

• Mar 4, 2019
• 1:59

FDA could approve ketamine spray as depression treatment

The drug can only be used in a doctor's office, and is in the form of a nasal spray

• Mar 4, 2019

More blood pressure drugs recalled due to cancer risk

In recent months, multiple drugmakers have recalled medications after tests revealed traces of carcinogens

• Mar 1, 2019

FDA raises concerns about dietary supplements

The FDA is warning about harmful dietary supplements. The agency is alerting consumers about false claims, unknown ingredients, and potentially harmful products. Americans spent more than $40 billion on supplements last year, and three out of four Americans regularly take a supplement. Dr. David Agus joins "CBS This Morning" with more on the supplement regulation.

• Feb 22, 2019
• 4:18

Did the FDA ignite the opioid epidemic?

A drug manufacturer denounces his own industry and explains to 60 Minutes how a label change by the FDA expanded the use of opioids

• Feb 24, 2019

FDA raises concerns dietary supplements

According to the Food and Drug Administration, three out of four Americans take dietary supplements on a regular basis. But the $40 billion industry is not highly regulated. FDA commissioner Scott Gottlieb recently announced plans to make the most significant changes to supplement regulation in a quarter century. Dr. David Agus joins “CBS This Morning: Saturday” to discuss.

• Feb 23, 2019
• 4:23

FDA warns about potentially harmful dietary supplements

Americans spent more than $40 billion on supplements last year, with 3 out of 4 people regularly taking them

• Feb 22, 2019

Former FDA commish on agency role in opioid epidemic

Dr. David Kessler, who was FDA commissioner in the 1990s, tells 60 Minutes, "There are no studies on the safety or efficacy of opioids for long-term use." Sunday at 7 p.m. ET/PT on CBS

• Feb 21, 2019

Startup halts treatment using young people's blood after warning

Ambrosia Health charged thousands of dollars for infusions of plasma from teens and young adults

• Feb 19, 2019

Nature's Path recalls gluten-free cereal due to undeclared gluten

Food maker recalls some batches of gluten-free product sold around the U.S. because it may contain wheat and barley

• Feb 19, 2019

Salmonella outbreak hitting pet food brands

At least two makers of animal food have been affected by a widespread turkey recall that has sickened hundreds

• Feb 19, 2019

Drugmaker behind ibuprofen recall has history of FDA violations

Federal watchdog previously found significant violations of manufacturing rules by Tris Pharma

• Feb 13, 2019

FDA warns against false supplement claims

The U.S. Food and Drug Administration issued a warning against companies whose products are being "illegally marketed." The FDA said one company claimed its product could even reduce symptoms of "cognitive decline." Anna Werner reports.

• Feb 11, 2019
• 1:51

FDA announces crackdown on illegal dietary supplements

In one case, the FDA found a company claimed its product reduced "symptoms of cognitive decline"

• Feb 11, 2019

CBD fans want edibles, but some states are cracking down

States are cracking down on cannabidiol-infused food over safety concerns -- some in the industry say it's warranted

• Feb 11, 2019

Pet owners report dog deaths from recalled food

While one company is facing rash of unhappy consumers, it's one of at least nine that distributed potentially toxic food

• Feb 8, 2019

Show More